RavenQuest BioMed Inc. Logo

RavenQuest BioMed Inc.

RVVQF

(0.0)
Stock Price

0,00 USD

-157.23% ROA

-203.42% ROE

-0x PER

Market Cap.

658.422,45 USD

59.22% DER

0% Yield

-2424.36% NPM

RavenQuest BioMed Inc. Stock Analysis

RavenQuest BioMed Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

RavenQuest BioMed Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

RavenQuest BioMed Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

RavenQuest BioMed Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

RavenQuest BioMed Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

RavenQuest BioMed Inc. Revenue
Year Revenue Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 112.351 100%
2018 1.256.740 91.06%
2019 2.838.568 55.73%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

RavenQuest BioMed Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 80.000 100%
2019 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

RavenQuest BioMed Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 68.276
2009 91.636 25.49%
2010 82.122 -11.59%
2011 110.531 25.7%
2012 134.054 17.55%
2013 100.620 -33.23%
2014 84.037 -19.73%
2015 79.390 -5.85%
2016 80.118 0.91%
2017 634.098 87.37%
2018 10.237.923 93.81%
2019 8.080.248 -26.7%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

RavenQuest BioMed Inc. EBITDA
Year EBITDA Growth
2008 -68.276
2009 -91.636 25.49%
2010 -82.122 -11.59%
2011 -110.531 25.7%
2012 -368.532 70.01%
2013 291.929 226.24%
2014 -62.337 568.31%
2015 -76.089 18.07%
2016 -81.458 6.59%
2017 -641.324 87.3%
2018 -15.294.711 95.81%
2019 -7.803.736 -95.99%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

RavenQuest BioMed Inc. Gross Profit
Year Gross Profit Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 14.654 100%
2018 801.292 98.17%
2019 1.771.276 54.76%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

RavenQuest BioMed Inc. Net Profit
Year Net Profit Growth
2008 -68.120
2009 -90.705 24.9%
2010 -82.068 -10.52%
2011 -85.435 3.94%
2012 100.500 185.01%
2013 -502.223 120.01%
2014 -60.567 -729.2%
2015 -76.029 20.34%
2016 -81.458 6.66%
2017 -3.301.027 97.53%
2018 -30.467.863 89.17%
2019 -12.496.088 -143.82%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

RavenQuest BioMed Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

RavenQuest BioMed Inc. Free Cashflow
Year Free Cashflow Growth
2008 -62.113
2009 -41.955 -48.05%
2010 -235.098 82.15%
2011 -200.609 -17.19%
2012 -107.317 -86.93%
2013 -35.130 -205.49%
2014 -36.620 4.07%
2015 -19.711 -85.78%
2016 -32.447 39.25%
2017 -2.511.383 98.71%
2018 -23.361.925 89.25%
2019 -2.092.944 -1016.22%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

RavenQuest BioMed Inc. Operating Cashflow
Year Operating Cashflow Growth
2008 -62.113
2009 -41.955 -48.05%
2010 -168.348 75.08%
2011 -90.108 -86.83%
2012 -107.317 16.04%
2013 -40.954 -162.04%
2014 -36.620 -11.84%
2015 -19.711 -85.78%
2016 -32.447 39.25%
2017 -2.510.431 98.71%
2018 -11.101.970 77.39%
2019 -1.437.868 -672.11%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

RavenQuest BioMed Inc. Capital Expenditure
Year Capital Expenditure Growth
2008 0
2009 0 0%
2010 66.750 100%
2011 110.501 39.59%
2012 0 0%
2013 -5.824 100%
2014 0 0%
2015 0 0%
2016 0 0%
2017 952 100%
2018 12.259.955 99.99%
2019 655.076 -1771.53%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

RavenQuest BioMed Inc. Equity
Year Equity Growth
2008 92.783
2009 2.078 -4365.01%
2010 420.010 99.51%
2011 359.575 -16.81%
2012 270.075 -33.14%
2013 -232.148 216.34%
2014 -292.715 20.69%
2015 -368.744 20.62%
2016 -450.202 18.09%
2017 7.568.826 105.95%
2018 22.389.601 66.19%
2019 20.532.211 -9.05%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

RavenQuest BioMed Inc. Assets
Year Assets Growth
2008 180.362
2009 170.992 -5.48%
2010 453.850 62.32%
2011 408.935 -10.98%
2012 441.436 7.36%
2013 40.011 -1003.29%
2014 13.667 -192.76%
2015 8.225 -66.16%
2016 8.699 5.45%
2017 8.699.909 99.9%
2018 37.704.606 76.93%
2019 39.484.609 4.51%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

RavenQuest BioMed Inc. Liabilities
Year Liabilities Growth
2008 87.579
2009 168.914 48.15%
2010 33.840 -399.15%
2011 49.360 31.44%
2012 171.361 71.2%
2013 272.159 37.04%
2014 306.382 11.17%
2015 376.969 18.72%
2016 458.901 17.85%
2017 1.131.083 59.43%
2018 15.315.005 92.61%
2019 18.952.398 19.19%

RavenQuest BioMed Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.01
Net Income per Share
-0.33
Price to Earning Ratio
-0x
Price To Sales Ratio
0.52x
POCF Ratio
-0
PFCF Ratio
-0.03
Price to Book Ratio
0
EV to Sales
10.79
EV Over EBITDA
-0.89
EV to Operating CashFlow
-1.22
EV to FreeCashFlow
-0.58
Earnings Yield
-24506.54
FreeCashFlow Yield
-35.48
Market Cap
0,00 Bil.
Enterprise Value
0,01 Bil.
Graham Number
1.36
Graham NetNet
-0.15

Income Statement Metrics

Net Income per Share
-0.33
Income Quality
0.36
ROE
-2.03
Return On Assets
-0.81
Return On Capital Employed
-0.48
Net Income per EBT
0.98
EBT Per Ebit
1.81
Ebit per Revenue
-13.67
Effective Tax Rate
0.02

Margins

Sales, General, & Administrative to Revenue
8.15
Research & Developement to Revenue
0.06
Stock Based Compensation to Revenue
4.9
Gross Profit Margin
0.64
Operating Profit Margin
-13.67
Pretax Profit Margin
-24.7
Net Profit Margin
-24.24

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.12
Free CashFlow per Share
-0.26
Capex to Operating CashFlow
-1.1
Capex to Revenue
9.76
Capex to Depreciation
6.52
Return on Invested Capital
-0.47
Return on Tangible Assets
-1.57
Days Sales Outstanding
292.22
Days Payables Outstanding
1647.94
Days of Inventory on Hand
713.13
Receivables Turnover
1.25
Payables Turnover
0.22
Inventory Turnover
0.51
Capex per Share
0.13

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,25
Tangible Book Value per Share
0.04
Shareholders Equity per Share
0.25
Interest Debt per Share
0.17
Debt to Equity
0.59
Debt to Assets
0.35
Net Debt to EBITDA
-0.84
Current Ratio
1.14
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
35644297
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.49
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
444922.5
Debt to Market Cap
20.14

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

RavenQuest BioMed Inc. Dividends
Year Dividends Growth

RavenQuest BioMed Inc. Profile

About RavenQuest BioMed Inc.

RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.

CEO
Mr. W. George Robinson
Employee
0
Address
580 Hornby Street
Vancouver, V6E 2K3

RavenQuest BioMed Inc. Executives & BODs

RavenQuest BioMed Inc. Executives & BODs
# Name Age
1 Mr. Shayne Taker
Head of Orbital Garden Mfg & Procurement
70
2 Ms. Marla K. Ritchie
Corporate Secretary
70
3 Mr. Mathieu David Mcdonald
Head of Corporate Communications
70
4 Mr. W. George Robinson
Chief Executive Officer, President & Director
70
5 Andy Schinke
Head of Sales & Product Acquisition
70

RavenQuest BioMed Inc. Competitors